InVita DNA & Forensic Sample Management Division’s Post

🔬 **Enhancing Drug Safety: Minimizing Nitrosamines in Pharmaceuticals** 🌍 With increasing scrutiny on nitrosamines—potentially harmful impurities—it's crucial for pharmaceutical manufacturers to safeguard public health. ✨ **Key Takeaways:** - Choose high-purity raw materials - Optimize manufacturing processes - Utilize advanced detection methods - Implement continuous monitoring - Adjust formulation pH to reduce nitrosamine risk By adopting these measures, we can improve medicine quality and foster greater industry trust. and now answer this question: https://lnkd.in/dUFRKbaB Also visit: https://lnkd.in/dWbb9-cJ #Pharmaceuticals #DrugSafety #Nitrosamines #QualityControl #Healthcare

🚨 𝗛𝗜𝗚𝗛 𝗔𝗟𝗘𝗥𝗧 🚨 𝗟𝗮𝘁𝗲𝘀𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 𝗕𝘂𝘇𝘇! 💊 📢 𝗚𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗶𝘀𝘀𝘂𝗲𝘀 𝗮𝗹𝗲𝗿𝘁: 𝗖𝗗𝗦𝗖𝗢 𝗳𝗹𝗮𝗴𝘀 𝟱𝟴 𝘀𝘂𝗯𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗱𝗿𝘂𝗴𝘀 𝗮𝗻𝗱 𝗼𝘂𝘁𝗹𝗶𝗻𝗲𝘀 𝗱𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 𝗴𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 𝘁𝗼 𝗮𝗱𝗱𝗿𝗲𝘀𝘀 𝘁𝗵𝗲 𝗶𝘀𝘀𝘂𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗽𝗵𝗮𝗿𝗺𝗮 𝗺𝗮𝗿𝗸𝗲𝘁. The Central Drugs Standard Control Organization (CDSCO) has raised concerns over the quality of 58 pharmaceutical products. To combat this, strict distribution guidelines have been issued to ensure only safe and effective drugs reach consumers. 👩⚕️👨⚕️ It's crucial to Prioritize Patient safety and Quality assurance in the pharmaceutical industry. 𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘆𝗼𝘂𝗿 𝘁𝗵𝗼𝘂𝗴𝗵𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲𝘀𝗲 𝗡𝗲𝘄 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀? #Pharma #Pharmanews #healthcare #storytelling

The new CDSCO FDA India MoHFW draft guidelines, aligned with the WHO Technical Report Series on Good Storage and Distribution Practices for Pharmaceutical Products, are aimed at safeguarding the integrity of the supply chain. They hold every player accountable—from manufacturers to distributors and retailers—ensuring a quality-first approach at each stage.   By stringent enforcement and fostering collaboration across the chain, the objectives are to eliminate risks like adulteration, misbranding and unauthorized tampering, ensuring safer products for patients. Dr. Rajen Ghadiok Ravi Oberoi Pragya Nalwa Akanksha Jha Shreshth Sinha #Pharmaceutical #CDSCO #GDP #PharmaQuality #SupplyChain #Healthcare  

Key Benefits of the LIFESAVER Innovation for Pharmaceutical Companies: • Early Risk Detection: Identify potential risks to the developing fetus in the early stages of drug development, optimization or repurposing. • Regulatory Confidence: Enhance your compliance with regulatory standards by integrating this cutting-edge tool into your drug safety protocols - also for pregnancy-indicated drugs. • Cost Efficiency: Reduce the costs associated with late-stage failures and streamline your R&D process. Be the first to receive news of the project’s development by subscribing to our newsletter here: https://tally.so/r/3x7oym #LifeSaverH2020 #H2020 #EUFunded #EUHealthResearch #greendeal #FetalSafety #PharmaInnovation #DrugDevelopment #PrenatalCare #HealthcareInnovation #LIFESAVER #Biotech #Pharmaceuticals #RegulatoryCompliance #DrugSafety #fetalhealth #maternalhealth

📢 In April, Medicines for Europe released a position paper doubting the impact of stockpiling on tackling drug shortages. Aiming at drug shortages, a critical medicines list covering 312 active pharmaceutical ingredients is entering into force on the 10th of May 2024, introducing stockpiling obligations for wholesalers operating in Hungary. We looked on the impact of the new legislation. 💬 If you have any questions, please contact us in the comments or by message. 🔗 The sources are available in the comments section. #drugshortage #stockpiling #government #policymeasures

FDA Issues Warning Against SnoreStop Nasal Spray Due to Contamination Risks The FDA has issued a warning advising consumers not to use SnoreStop Nasal Spray, produced by Green Pharmaceuticals, due to microbial contamination risks, which could be especially harmful to immune-compromised individuals. Despite multiple FDA recommendations, Green Pharmaceuticals has not initiated a recall, raising concerns over consumer safety. The FDA had previously inspected the facility and detected contamination in April 2024, and consumers are urged to report adverse effects through the FDA’s MedWatch system. The inspection findings and lack of recall action have led to continued safety concerns. For more details please click the link! https://lnkd.in/duqH-VWX #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

In the pharmaceutical industry, the impact of fake medicines extends beyond patient health. 🔒 It also degrades brand integrity and trust. Addressing this issue is critical to ensuring the safety of patients and the credibility of pharmaceutical companies. Implementing robust anti-counterfeit measures is key to safeguarding both lives and reputations. 💊 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲 ➡️ https://bit.ly/3XdjDsD . . #Lasersec #packaging #productpackaging #anticounterfeit #PharmaIndustry #PatientSafety #AntiCounterfeit #BrandProtection

India's Pharmaceutical Gem: Beyond the Obvious! Non-hormonal alkaloids play a key role in many medications, and India's a major exporter! We connect you with reliable manufacturers for these & other ingredients. Contact us today to explore your options for sourcing high-quality products. https://lnkd.in/dr9BMYVv #industryexperts #business #growth #industryexpertspvtltd #indianmanufacturing #export #foreigntrade #India #Pharmaceuticals #ContractManufacturing #GlobalTrade #HiddenGems #PharmaceuticalIndustry #IndianPharma #HealthcareInnovation #MedicalManufacturing #GlobalHealth #SupplyChainSolutions #ContractManufacturing #PharmaExport #MedicationDevelopment #HealthcarePartnerships #PharmaInnovation #ContractManufacturing #GlobalHealthcare

#Pharmacist #Alert 🌀 𝑬𝒏𝒔𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒆 𝒄𝒐𝒓𝒓𝒆𝒄𝒕 𝒕𝒆𝒎𝒑𝒆𝒓𝒂𝒕𝒖𝒓𝒆 𝒊𝒔 𝒏𝒐𝒕 𝒋𝒖𝒔𝒕 𝒂𝒃𝒐𝒖𝒕 𝒑𝒓𝒆𝒗𝒆𝒏𝒕𝒊𝒏𝒈 𝒆𝒙𝒕𝒓𝒆𝒎𝒆𝒔 🌀⚠️ It's about maintaining a consistent environment where pharmaceutical products can be safely stored and remain effective. ❄ Many pharmaceutical products, such as 𝐯𝐚𝐜𝐜𝐢𝐧𝐞𝐬, 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬, 𝐚𝐧𝐝 𝐜𝐞𝐫𝐭𝐚𝐢𝐧 𝐦𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬, must be stored within a specific temperature range to maintain their efficacy. ❄ These ranges aren't merely suggestions—they're 𝐬𝐭𝐫𝐢𝐧𝐠𝐞𝐧𝐭 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬. Deviation can result in the degradation of the product, leading to compromised safety and efficacy. ❄ In worst-case scenarios, temperature fluctuations can render entire batches unusable, leading to significant financial loss and potential health risks. 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞: https://lnkd.in/gcnGhy9H #clinicalpharmacist #pharmacist #shareknowledge #patientcounseling #medicalwriter #letsconnect

Unlocking the Future of Pharmaceutical Manufacturing: Introducing CRABS 🦀✨ Dive into the next level of sterile production with Closed Restricted Access Barrier Systems (CRABS), providing unparalleled protection against contamination in drug manufacturing. 🌐💊 #PharmaInnovation #SterileManufacturing #CRABS #sterility #sterileprocessing #sterilization Disclaimer: This information has no link with Baxter or Baxter product/process or any information or anything that could identify company’s, colleague’s, vendor’s, patient’s, investor’s, or stakeholder’s personal information”.